Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression

Since the start of the SARS-CoV-2 pandemic, several treatments have been proposed to prevent the progression of the disease. Currently, three antiviral (molnupiravir, nirmaltrevir/r, remdesivir) and two monoclonal antibodies (casirivimab/imdevimab and sotrovimab) are available in Italy. Therefore, w...

Descripción completa

Detalles Bibliográficos
Autores principales: De Vito, Andrea, Colpani, Agnese, Saderi, Laura, Puci, Mariangela, Zauli, Beatrice, Fiore, Vito, Fois, Marco, Meloni, Maria Chiara, Bitti, Alessandra, Di Castri, Cosimo, Maida, Ivana, Babudieri, Sergio, Sotgiu, Giovanni, Madeddu, Giordano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865563/
https://www.ncbi.nlm.nih.gov/pubmed/36680111
http://dx.doi.org/10.3390/v15010071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865563/
https://www.ncbi.nlm.nih.gov/pubmed/36680111
http://dx.doi.org/10.3390/v15010071

Ejemplares similares